eBioMedicine, 2022 Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma Rossi N., Lee K., Bermudez M. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationSerum | | | | |
Science Advances, 2022 Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods Katz D., Robbins J., Deng S. et al. Olink Explore 3072/384Wider Proteomics StudiesTechnical EvaluationPlasma | | | | |
Molecular Psychiatry, 2022 Cerebrospinal fluid proteomic study of two bipolar disorder cohorts Isgren A., Göteson A., Holmén-Larsson J. et al. NeurologyPathophysiologyPatient StratificationCSF | | | | |
Physiological Reports, 2022 Quantifying the inflammatory secretome of human intermuscular adipose tissue Kahn D., Macias E., Zarini S. et al. Olink Target 96Metabolic DiseasesPathophysiologyCell Culture Supernatant | | | | |
Scientific Reports, 2022 Association of extracellular vesicle inflammatory proteins and mortality Noren Hooten N., Torres S., Mode N. et al. Olink Target 96Wider Proteomics StudiesPatient StratificationEV Lysate | | | | |
Journal of Clinical Immunology, 2022 SOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK Inhibition Michniacki T., Walkovich K., DeMeyer L. et al. Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
American Journal of Respiratory Cell and Molecular Biology, 2022 Multiomic Signatures of Chronic Beryllium Disease Bronchoalveolar Lavage Cells Relate to T-Cell Function and Innate Immunity Li L., Konigsberg I., Bhargava M. et al. Olink Target 96Respiratory DiseasesPathophysiologyBALF | | | | |
International Journal of Molecular Sciences, 2022 Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery Beltrami A., De Martino M., Dalla E. et al. Olink Target 96Infectious DiseasesPatient StratificationSerum | | | | |
Nature Communications, 2022 ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19 Pietzner M., Chua R., Wheeler E. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Nordic Journal of Psychiatry, 2022 Intercorrelation of physiological seizure parameters and hormonal changes in electroconvulsive therapy Thörnblom E., Gingnell M., Cunningham J. et al. Olink Target 96NeurologyPathophysiologySerum | | | | |
Multiple Sclerosis and Related Disorders, 2022 High-intensity resistance training in people with multiple sclerosis experiencing fatigue: A randomised controlled trial Englund S., Piehl F., Kierkegaard M. Olink Target 96NeurologyPatient StratificationSerum | | | | |
Journal of Molecular and Cellular Cardiology Plus, 2022 Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes Schulte C., Singh B., Theofilatos K. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Nature Cardiovascular Research, 2022 Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension Boucherat O., Yokokawa T., Krishna V. et al. Olink Explore 3072/384CVDPathophysiologyPatient StratificationPlasma | | | | |
American Heart Journal Plus: Cardiology Research and Practice, 2022 Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension Helleberg S., Engel A., Ahmed S. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Fluids and Barriers of the CNS, 2022 Posthemorrhagic hydrocephalus associates with elevated inflammation and CSF hypersecretion via activation of choroidal transporters Lolansen S., Rostgaard N., Barbuskaite D. et al. Olink Target 96NeurologyPathophysiologyCSF | | | | |
International Journal of Obesity, 2022 Heart failure in obesity: insights from proteomics in patients treated with or without weight-loss surgery Karason K., Girerd N., Andersson-Asssarsson J. et al. Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma | | | | |
PROTEOMICS – Clinical Applications, 2022 Plasma biomarkers for systemic inflammation in COVID‐19 survivors Zhao J., Schank M., Wang L. et al. Olink Target 96Infectious DiseasesPatient StratificationPlasma | | | | |
Journal of Investigative Dermatology, 2022 Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis Wang C., Haxhinasto S., Garcet S. et al. Olink Target 96Dermatological DiseasesPathophysiologySerum | | | | |
Rheumatology, 2022 Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression Szilagyi I., Vallerga C., Boer C. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
Diabetologia, 2022 Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality Bao X., Xu B., Muhammad I. et al. Olink Target 96OncologyMetabolic DiseasesPatient StratificationPlasma | | | | |